Cargando…
The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder
Patients with bipolar II disorder (BDII) have a higher prevalence rate of metabolic disturbance. Whether BDII itself, in addition to its current standard treatment, is a risk factor for metabolic syndrome warrants additional study. The dopamine receptor D3 (DRD3) gene, one of the candidate genes for...
Autores principales: | Chang, Ting-Ting, Chen, Shiou-Lan, Chang, Yun-Hsuan, Chen, Po-See, Chu, Chun-Hsien, Chen, Shih-Heng, Huang, San-Yuan, Tzeng, Nian-Sheng, Wang, Liang-Jen, Wang, Tzu-Yun, Li, Chia-Ling, Chung, Yi-Lun, Hsieh, Tsai-Hsin, Lee, I-Hui, Chen, Kao-Ching, Yang, Yen-Kuang, Hong, Jau-Shyong, Lu, Ru-Band, Lee, Sheng-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998429/ https://www.ncbi.nlm.nih.gov/pubmed/27310943 http://dx.doi.org/10.1097/MD.0000000000003488 |
Ejemplares similares
-
Inflammation’s Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder
por: Lee, Sheng-Yu, et al.
Publicado: (2013) -
Combination of dextromethorphan and memantine in treating bipolar spectrum disorder: a 12-week double-blind randomized clinical trial
por: Lee, Sheng-Yu, et al.
Publicado: (2020) -
The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder: Erratum
Publicado: (2016) -
Relationships between dorsolateral prefrontal cortex metabolic change and cognitive impairment in first-episode neuroleptic-naive schizophrenia patients
por: Huang, Man-Li, et al.
Publicado: (2017) -
Dextromethorphan Protect the Valproic Acid Induced Downregulation of Neutrophils in Patients with Bipolar Disorder
por: Lu, Ru-Band, et al.
Publicado: (2020)